Drug Type Biological products  | 
Synonyms pepteron, RPI MN  | 
Action stimulants, antagonists  | 
Mechanism IFNγ stimulants(Interferon gamma stimulants), Muscle-type nAChRs antagonists(Muscle-type nicotinic acetylcholine receptor antagonists)  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhaseDiscontinuedPhase 2  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| HIV Infections | Phase 2 | China   | - | |
| HIV Infections | Phase 2 | South America   | - | |
| HIV Infections | Phase 2 | - | - | |
| Keratitis, Herpetic | Phase 1 | United States   | 24 Feb 2021 | |
| Amyotrophic Lateral Sclerosis | Phase 1 | United States   | 23 Nov 2015 | |
| Virus Diseases | Phase 1 | Mexico   | - | |
| Virus Diseases | Phase 1 | Peru   | - | |
| Herpes Simplex | Preclinical | United States   | - | 





